Are midline catheters safe and effective in everyday care?
Official title: A Prospective, Multicenter, Real-World Clinical Study Provides an Assessment of the Safety and Efficacy of Midline Catheters
Run by Shandong Branden Med.Device Co.,Ltd · NCT07677696 · Data updated 2026-11-12
This study tests whether midline catheters used in routine care are safe and effective for adults needing IV therapy for up to four weeks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Shandong Branden Med.Device Co.,Ltd Industry-sponsored |
| Locations | 1 site (Zibo) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT07677696 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) receiving their first midline catheter placement and able to consent and comply with follow-up.
✕Probably not a fit
Patients who do not receive a midline catheter or who are unable to participate in follow-up may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter observational study conducted in China to examine the real-world safety and effectiveness of midline catheters. Researchers will collect data from electronic medical records and patient questionnaires to track catheter-related complications and functional performance during routine use. The study aims to identify risk factors for complications and to inform improvements in usage, maintenance, and prevention strategies. Participants are adults receiving their first midline catheter placement as part of standard care, followed across multiple sites. No experimental interventions beyond standard catheter placement are involved.
Why it matters
Potential benefit: If successful, findings could lead to safer practices and standardized protocols for midline catheter use in routine clinical care.
How similar studies have gone: Previous real-world studies have provided important safety data for midline catheters in other settings, but data specific to China are limited and this study seeks to fill that gap.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * First-time midline catheter placement per physician order * Not enrolled in another clinical study * Willing and able to provide informed consent and comply with follow-up (unless consent waived by local ethics committee) Exclusion Criteria: * Deemed unsuitable by investigator (e.g., poor compliance or inability to communicate clearly) * Refusal of informed consent by patient or family member
Where it's running
-
Zibo Central Hospital
Zibo, China Recruiting
Study contacts
- Study coordinator: Lina Zhang
- Email: 1173565974@qq.com
- Phone: +86-18678187002
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SpadCare: digital home-care program for patients with PICC lines
This program tests a smartphone app that teaches and remotely monitors adults with PICC lines who receive home infusions to help reduce catheter complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.